Lentiviral–mediated short hairpin RNA (shRNA) specifically targeting human GMDS was employed to inhibit GMDS expression in lung adenocarcinoma cells, and knockdown efficiency was confirmed at both mRNA and protein level by quantitative real-time polymerase chain reaction (qPCR) and western blot. This evidence concerns the gene GMDS and lung adenocarcinoma.